George Karpati

发表

Gene shifting: a novel therapy for mitochondrial myopathy.

E. Shoubridge, T. Taivassalo, T. Johns, 1999, Human molecular genetics.

Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease

K. Walker, K. Creed, L. Davies, 2014, Neuromuscular Disorders.

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene

K. Davies, M. Wood, J. Tinsley, 2000, Gene Therapy.

Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).

E. Shoubridge, L. Boulet, G. Karpati, 1992, American journal of human genetics.

Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.

Y. Pouliot, P. Ray, R. Worton, 1989, The American journal of pathology.

Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells.

G. Pari, P. Holland, J. Nalbantoglu, 1999, Human gene therapy.

Effects of aerobic training in patients with mitochondrial myopathies

P. Matthews, D. Arnold, T. Taivassalo, 1998, Neurology.

Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers.

R. Hodges, O. Hutter, D. Bulman, 1991, Experimental cell research.

Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease.

S. Scherer, P. Taschner, A. Odermatt, 1997, Genomics.

Quantitative morphometric study of muscle in inclusion body myositis

J. F. Brenner, W. Bradley, L. Adelman, 1992, Journal of the Neurological Sciences.

Myophosphorylase gene transfer in McArdle’s disease myoblasts in vitro

G. Pari, E. Shoubridge, S. Dimauro, 1999, Neurology.

Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle’s disease: Expression and re-expression of glycogen phosphorylase

N. Laing, A. Everaardt, G. Karpati, 2008, Neuromuscular Disorders.

Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.

J. Nalbantoglu, S. Ebihara, B. Massie, 2000, Human gene therapy.

Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

Hanns Lochmüller, J. Nalbantoglu, L. Yang, 1998, Gene Therapy.

The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells

K. Davies, G. Karpati, P. Holland, 1995, Neuromuscular Disorders.

Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.

K. Davies, B. Massie, J. Tinsley, 1998, Biochemical and biophysical research communications.

Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.

A. Sadikot, P. Seth, J. Nalbantoglu, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.